ALNY doesn't need cash for the buyout. ALNY is a one billion dollar company with 50 million shares outstanding. They can swallow TKMR with a stock transaction. It would alleviate any uncertainty for the lawsuit outcome and enable ALNY to pursue their own collaborative agreement with a larger pharma company. No major company is going to partner with them until their problems with TKMR are resolved. They must know this and I am betting that they are in negotiations as we speak. Why else would TKMR be going up and up every day?